Drug General Information |
Drug ID |
D0EF7D
|
Former ID |
DNC001276
|
Drug Name |
SB 202190
|
Drug Type |
Small molecular drug
|
Indication |
Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89]
|
Investigative |
[1]
|
Therapeutic Class |
Analgesics
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C20H14FN3O
|
InChI |
InChI=1S/C20H14FN3O/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(25)8-4-15/h1-12,25H,(H,23,24)
|
InChIKey |
QHKYPYXTTXKZST-UHFFFAOYSA-N
|
CAS Number |
CAS 152121-30-7
|
PubChem Compound ID |
|
PubChem Substance ID |
647319, 4331462, 7953022, 11111814, 11114007, 11120359, 11120847, 11121335, 11121738, 11122218, 11362860, 11365422, 11367984, 11370931, 11370932, 11373585, 11376146, 14875241, 16770907, 17404736, 24262977, 24278272, 26752145, 26752146, 26759477, 26759482, 26759487, 37494338, 39379797, 46516044, 47349352, 47364985, 47736256, 48110249, 48169360, 48334264, 50070513, 50071151, 50100114, 50104791, 50104792, 50104793, 50826030, 53777279, 53788890, 53800550, 53800553, 56311741, 56463269, 57361610
|
Target and Pathway |
Target(s) |
Mitogen-activated protein kinase 14 |
Target Info |
Inhibitor |
[2]
|
Prostaglandin G/H synthase 2 |
Target Info |
Inhibitor |
[3]
|
BioCyc Pathway
|
Aspirin-triggered lipoxin biosynthesis
|
Aspirin triggered resolvin D biosynthesis
|
C20 prostanoid biosynthesis
|
Aspirin triggered resolvin E biosynthesis
|
KEGG Pathway
|
MAPK signaling pathway
|
Rap1 signaling pathway
|
FoxO signaling pathway
|
Sphingolipid signaling pathway
|
Adrenergic signaling in cardiomyocytes
|
VEGF signaling pathway
|
Osteoclast differentiation
|
Signaling pathways regulating pluripotency of stem cells
|
Platelet activation
|
Toll-like receptor signaling pathway
|
NOD-like receptor signaling pathway
|
RIG-I-like receptor signaling pathway
|
T cell receptor signaling pathway
|
Fc epsilon RI signaling pathway
|
TNF signaling pathway
|
Leukocyte transendothelial migration
|
Neurotrophin signaling pathway
|
Retrograde endocannabinoid signaling
|
Dopaminergic synapse
|
Inflammatory mediator regulation of TRP channels
|
GnRH signaling pathway
|
Progesterone-mediated oocyte maturation
|
Prolactin signaling pathway
|
Amyotrophic lateral sclerosis (ALS)
|
Epithelial cell signaling in Helicobacter pylori infection
|
Shigellosis
|
Salmonella infection
|
Pertussis
|
Leishmaniasis
|
Chagas disease (American trypanosomiasis)
|
Toxoplasmosis
|
Tuberculosis
|
Hepatitis C
|
Influenza A
|
Epstein-Barr virus infection
|
Proteoglycans in cancerhsa00590:Arachidonic acid metabolism
|
Metabolic pathways
|
NF-kappa B signaling pathway
|
Serotonergic synapse
|
Ovarian steroidogenesis
|
Oxytocin signaling pathway
|
Regulation of lipolysis in adipocytes
|
Pathways in cancer
|
Chemical carcinogenesis
|
MicroRNAs in cancer
|
Small cell lung cancer
|
NetPath Pathway
|
IL5 Signaling Pathway
|
FSH Signaling Pathway
|
TCR Signaling PathwayNetPath_13:IL1 Signaling Pathway
|
TSH Signaling Pathway
|
IL4 Signaling Pathway
|
TGF_beta_Receptor Signaling Pathway
|
PANTHER Pathway
|
Alzheimer disease-amyloid secretase pathway
|
Angiogenesis
|
B cell activation
|
EGF receptor signaling pathway
|
FGF signaling pathway
|
Interferon-gamma signaling pathway
|
Oxidative stress response
|
Parkinson disease
|
TGF-beta signaling pathway
|
Toll receptor signaling pathway
|
VEGF signaling pathway
|
Ras Pathway
|
p53 pathway feedback loops 2
|
p38 MAPK pathway
|
CCKR signaling map STP00019:Endothelin signaling pathway
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
CCKR signaling map ST
|
Pathway Interaction Database
|
Endothelins
|
BCR signaling pathway
|
p73 transcription factor network
|
p38 MAPK signaling pathway
|
Atypical NF-kappaB pathway
|
IL4-mediated signaling events
|
CD40/CD40L signaling
|
IL12-mediated signaling events
|
Regulation of p38-alpha and p38-beta
|
CDC42 signaling events
|
Angiopoietin receptor Tie2-mediated signaling
|
FAS (CD95) signaling pathway
|
Thromboxane A2 receptor signaling
|
Role of Calcineurin-dependent NFAT signaling in lymphocytes
|
Glucocorticoid receptor regulatory network
|
IL2-mediated signaling events
|
Rapid glucocorticoid signaling
|
Regulation of Androgen receptor activity
|
ATF-2 transcription factor network
|
IL6-mediated signaling events
|
p38 signaling mediated by MAPKAP kinases
|
Retinoic acid receptors-mediated signaling
|
CXCR3-mediated signaling events
|
Signaling mediated by p38-alpha and p38-beta
|
EPO signaling pathway
|
Signaling events mediated by VEGFR1 and VEGFR2
|
p53 pathway
|
S1P2 pathway
|
Trk receptor signaling mediated by the MAPK pathway
|
VEGFR3 signaling in lymphatic endothelium
|
FGF signaling pathway
|
RAC1 signaling pathway
|
Regulation of retinoblastoma proteinnfat_tfpathway:Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
S1P1 pathway
|
C-MYB transcription factor network
|
Calcium signaling in the CD4+ TCR pathway
|
PathWhiz Pathway
|
Fc Epsilon Receptor I Signaling in Mast CellsPW000044:Arachidonic Acid Metabolism
|
Reactome
|
NOD1/2 Signaling Pathway
|
p38MAPK events
|
ERK/MAPK targets
|
Activation of PPARGC1A (PGC-1alpha) by phosphorylation
|
Oxidative Stress Induced Senescence
|
CDO in myogenesis
|
DSCAM interactions
|
ADP signalling through P2Y purinoceptor 1
|
Platelet sensitization by LDL
|
VEGFA-VEGFR2 Pathway
|
activated TAK1 mediates p38 MAPK activation
|
Activation of the AP-1 family of transcription factors
|
KSRP (KHSRP) binds and destabilizes mRNA
|
WikiPathways
|
Toll-like receptor signaling pathway
|
Monoamine Transport
|
Serotonin HTR1 Group and FOS Pathway
|
TCR Signaling Pathway
|
Senescence and Autophagy in Cancer
|
Interferon type I signaling pathways
|
Insulin Signaling
|
EGF/EGFR Signaling Pathway
|
MAPK Cascade
|
Oxidative Stress
|
p38 MAPK Signaling Pathway
|
IL-4 Signaling Pathway
|
MAPK Signaling Pathway
|
TGF beta Signaling Pathway
|
Kit receptor signaling pathway
|
Cardiac Hypertrophic Response
|
MAP kinase activation in TLR cascade
|
Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
|
Nanoparticle-mediated activation of receptor signaling
|
Structural Pathway of Interleukin 1 (IL-1)
|
JAK/STAT
|
Amyotrophic lateral sclerosis (ALS)
|
Alpha 6 Beta 4 signaling pathway
|
Cardiac Progenitor Differentiation
|
BDNF signaling pathway
|
Integrated Pancreatic Cancer Pathway
|
Oncostatin M Signaling Pathway
|
Parkinsons Disease Pathway
|
Corticotropin-releasing hormone
|
AGE/RAGE pathway
|
B Cell Receptor Signaling Pathway
|
Prostate Cancer
|
TSLP Signaling Pathway
|
TWEAK Signaling Pathway
|
FSH signaling pathway
|
Leptin signaling pathway
|
RANKL/RANK Signaling Pathway
|
miR-targeted genes in muscle cell - TarBase
|
miR-targeted genes in lymphocytes - TarBase
|
miR-targeted genes in leukocytes - TarBase
|
miR-targeted genes in epithelium - TarBase
|
IL-1 signaling pathway
|
Signal amplification
|
Platelet homeostasis
|
NGF signalling via TRKA from the plasma membrane
|
Myogenesis
|
DSCAM interactions
|
MicroRNAs in cardiomyocyte hypertrophy
|
Angiogenesis
|
Physiological and Pathological Hypertrophy of the Heart
|
Regulation of toll-like receptor signaling pathwayWP98:Prostaglandin Synthesis and Regulation
|
Arachidonic acid metabolism
|
Aryl Hydrocarbon Receptor
|
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis
|
Spinal Cord Injury
|
Eicosanoid Synthesis
|
Selenium Micronutrient Network
|
References |
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4307). |
---|
REF 2 | Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia. Cardiovasc Res. 2003 Oct 1;59(4):893-900. |
---|
REF 3 | A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide-treated macrophage-like cell line, J774.1. Biochim Biophys Acta. 2000 Oct 18;1502(2):207-23. |